Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Functional polymorphism rs1024611 in the MCP1 gene is associated with the risk of varicose veins of lower extremities. / Shadrina, Alexandra S.; Smetanina, Mariya A.; Sevost'ianova, Kseniya S. и др.
в: Journal of Vascular Surgery: Venous and Lymphatic Disorders, Том 5, № 4, 01.07.2017, стр. 561-566.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Functional polymorphism rs1024611 in the MCP1 gene is associated with the risk of varicose veins of lower extremities
AU - Shadrina, Alexandra S.
AU - Smetanina, Mariya A.
AU - Sevost'ianova, Kseniya S.
AU - Seliverstov, Evgenii I.
AU - Ilyukhin, Evgeny A.
AU - Voronina, Elena N.
AU - Zolotukhin, Igor A.
AU - Filipenko, Maxim L.
N1 - Publisher Copyright: © 2017 Society for Vascular Surgery
PY - 2017/7/1
Y1 - 2017/7/1
N2 - Objective Monocyte chemoattractant protein 1 (MCP-1) is a chemokine responsible for monocyte, basophil, and T-lymphocyte attraction. Polymorphism rs1024611 located in the regulatory region of the MCP1 gene has previously been shown to be associated with increased MCP-1 production. In our study, we aimed to examine the association of rs1024611 with the risk of primary varicose veins (PVVs) of lower extremities. Methods The case group comprised 470 patients with PVVs, and the control group included 269 individuals without a history of chronic venous disease. All cases and controls were ethnic Russians. Genotypes were determined by real-time polymerase chain reaction allelic discrimination. Association was studied by logistic regression analysis. Results We revealed the association of genotype G/G with the increased risk of PVVs (odds ratio [OR], 1.87; 95% confidence interval [CI], 1.02-3.44; P = .04). In the subgroup analysis, association was revealed only in patients with C2 Clinical, Etiology, Anatomy, and Pathophysiology class (allele G: OR, 1.62 [95% CI, 1.13-2.33; P = .008]; genotype G/G: OR, 3.22 [95% CI, 1.43-7.27; P = .005]), in patients with age at onset of PVVs before 30 years (allele G: OR, 1.41 [95% CI, 1.08-1.85; P = .01]; genotype G/G: OR, 2.35 [95% CI, 1.22-4.55; P = .01]), and in patients who declared no family history (allele G: OR, 1.46 [95% CI, 1.02-2.09; P = .04]; genotype G/G: OR, 2.50 [95% CI, 1.11-5.63; P = .03]). Conclusions Our results provide evidence for MCP-1 involvement in the development of PVVs and indicate that inflammation could be implicated in the pathogenesis of this condition.
AB - Objective Monocyte chemoattractant protein 1 (MCP-1) is a chemokine responsible for monocyte, basophil, and T-lymphocyte attraction. Polymorphism rs1024611 located in the regulatory region of the MCP1 gene has previously been shown to be associated with increased MCP-1 production. In our study, we aimed to examine the association of rs1024611 with the risk of primary varicose veins (PVVs) of lower extremities. Methods The case group comprised 470 patients with PVVs, and the control group included 269 individuals without a history of chronic venous disease. All cases and controls were ethnic Russians. Genotypes were determined by real-time polymerase chain reaction allelic discrimination. Association was studied by logistic regression analysis. Results We revealed the association of genotype G/G with the increased risk of PVVs (odds ratio [OR], 1.87; 95% confidence interval [CI], 1.02-3.44; P = .04). In the subgroup analysis, association was revealed only in patients with C2 Clinical, Etiology, Anatomy, and Pathophysiology class (allele G: OR, 1.62 [95% CI, 1.13-2.33; P = .008]; genotype G/G: OR, 3.22 [95% CI, 1.43-7.27; P = .005]), in patients with age at onset of PVVs before 30 years (allele G: OR, 1.41 [95% CI, 1.08-1.85; P = .01]; genotype G/G: OR, 2.35 [95% CI, 1.22-4.55; P = .01]), and in patients who declared no family history (allele G: OR, 1.46 [95% CI, 1.02-2.09; P = .04]; genotype G/G: OR, 2.50 [95% CI, 1.11-5.63; P = .03]). Conclusions Our results provide evidence for MCP-1 involvement in the development of PVVs and indicate that inflammation could be implicated in the pathogenesis of this condition.
KW - MONOCYTE CHEMOATTRACTANT PROTEIN-1
KW - REGULATORY REGION
KW - MYOCARDIAL-INFARCTION
KW - DISEASE
KW - EXPRESSION
KW - ALLELE
KW - PATHOGENESIS
KW - METAANALYSIS
KW - CCL2
KW - Predictive Value of Tests
KW - Humans
KW - Middle Aged
KW - Male
KW - Case-Control Studies
KW - Russia
KW - Sensitivity and Specificity
KW - Aged, 80 and over
KW - Adult
KW - Biomarkers/blood
KW - Female
KW - Chemokine CCL2/blood
KW - Genetic Predisposition to Disease
KW - Risk Factors
KW - Hospitals, University
KW - Genotype
KW - Varicose Veins/diagnosis
KW - Adolescent
KW - Alleles
KW - Lower Extremity
KW - Aged
KW - Polymorphism, Single Nucleotide
UR - http://www.scopus.com/inward/record.url?scp=85013073319&partnerID=8YFLogxK
U2 - 10.1016/j.jvsv.2016.12.008
DO - 10.1016/j.jvsv.2016.12.008
M3 - Article
C2 - 28623996
AN - SCOPUS:85013073319
VL - 5
SP - 561
EP - 566
JO - Journal of Vascular Surgery: Venous and Lymphatic Disorders
JF - Journal of Vascular Surgery: Venous and Lymphatic Disorders
SN - 2213-333X
IS - 4
ER -
ID: 9133265